Abiopharma

DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference

TruBridge Announces Third Quarter 2025 Conference Call to Be Held Friday, November 7, 2025

Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy

Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10

New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner

Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

Coherent Announces Agreement to Sell Materials Processing Tools Product Division to Bystronic

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 17, 2025 in Cytokinetics, Incorporated Lawsuit - CYTK

Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR